Compliance-57 (5): intimation after the end of quarter
Filed with BSE · · 1 page · English
Transgene Biotek Limited on 6ix
Earlier from Transgene Biotek
- Compliance-57 (4): Prior intimation to the beginning of the quarter
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Transgene Biotek Limited. Press Release Sep 25 2026
- Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, We Wish To Inform You That The Company Has Received Approval From The Registrar Of Companies (ROC), Hyderabad, Telangana, For Extension Of Time
Later from Transgene Biotek
- Reg. 32(1) Statement Of Deviation & Variation.
- Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
Follow Transgene Biotek into a list and get an email when it puts out news.
Follow Transgene Biotek